推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Endocrine Metabolic & Immune Disorders-Drug Targets

2023年12月最新中科院分区表数据已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎点击此处反馈给我们。

按期刊名首写字母查看 ENDOCR METAB IM最新评论：每年可以的发文量少了点，所以不太好容易，审稿人挑了一些不好回答的问题。 (2018-08-28)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看：


Endocrine Metabolic & Immune Disorders-Drug Targets期刊基本信息Hello，您是该期刊的第19297位访客


基本信息 登录收藏
期刊名字Endocrine Metabolic & Immune Disorders-Drug TargetsEndocrine Metabolic & Immune Disorders-Drug Targets

ENDOCR METAB IMMUNE
（此期刊被最新的JCR期刊SCIE收录）

LetPub评分
5.3
50人评分
我要评分

声誉
6.3

影响力
3.8

速度
8.5

期刊ISSN1871-5303
微信扫码收藏此期刊
2022-2023最新影响因子
（数据来源于搜索引擎）		1.9 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日：1.951
2022-2023自引率5.30%点击查看自引率趋势图
五年影响因子2
h-index 44
CiteScore
CiteScoreSJRSNIPCiteScore排名
4.200.4270.591
学科分区排名百分位
大类：Medicine
小类：Endocrinology, Diabetes and Metabolism		Q2116 / 232
大类：Medicine
小类：Immunology and Allergy		Q3128 / 211

期刊简介
Aims & Scope

This journal is devoted to timely reviews and original articles of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and on microbioma composition are welcome.
期刊官方网站http://benthamscience.com/journal/index.php?journalID=emiddt
期刊投稿网址http://bsp-cms.eurekaselect.com/index.php/CDTIEMD
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Endocrine Metabolic & Immune Disorders-Drug Targets的语言要求，还能让Endocrine Metabolic & Immune Disorders-Drug Targets编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Endocrine Metabolic & Immune Disorders-Drug Targets编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿
是否OA开放访问No
通讯方式EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR
出版商Bentham Science Publishers B.V.
涉及的研究方向ENDOCRINOLOGY & METABOLISMIMMUNOLOGY-IMMUNOLOGY
出版国家或地区U ARAB EMIRATES
出版语言English
出版周期
出版年份0
年文章数 132点击查看年文章数趋势图
Gold OA文章占比0.00%
研究类文章占比：
文章 ÷（文章 + 综述）		52.27%
WOS期刊SCI分区
（ 2022-2023年最新版）		WOS分区等级：4区

按学科分区JIF分区JIF排名JIF百分位
学科：ENDOCRINOLOGY & METABOLISM
类别：SCIE		Q4128/145
学科：IMMUNOLOGY
类别：SCIE		Q4144/161
学科：PHARMACOLOGY & PHARMACY
类别：SCIE		Q4224/277
中科院《国际期刊预警
名单（试行）》名单 		2024年02月发布的2024版：不在预警名单中

2023年01月发布的2023版：不在预警名单中

2021年12月发布的2021版：不在预警名单中

2020年12月发布的2020版：不在预警名单中
中科院SCI期刊分区
（ 2023年12月最新升级版） 		点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 4区4区2区
ENDOCRINOLOGY & METABOLISM
内分泌学与代谢		4区4区4区
IMMUNOLOGY
免疫学		2区4区4区
PHARMACOLOGY & PHARMACY
药学		4区3区4区
否否
中科院SCI期刊分区
（ 2022年12月升级版）
大类学科小类学科Top期刊综述期刊
医学 3区4区3区
ENDOCRINOLOGY & METABOLISM
内分泌学与代谢		1区3区4区
IMMUNOLOGY
免疫学		3区3区4区
PHARMACOLOGY & PHARMACY
药学		1区2区4区
否否
中科院SCI期刊分区
（ 2021年12月旧的升级版）
大类学科小类学科Top期刊综述期刊
医学 4区4区2区
ENDOCRINOLOGY & METABOLISM
内分泌学与代谢		4区1区4区
IMMUNOLOGY
免疫学		2区2区4区
PHARMACOLOGY & PHARMACY
药学		2区1区4区
否否
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1871-5303%5BISSN%5D
平均审稿速度网友分享经验：

平均录用比例网友分享经验：
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Endocrine Metabolic & Immune Disorders-Drug Targets顺利发表。
快看看作者怎么说吧：服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Endocrine Metabolic & Immune Disorders-Drug Targets期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Endocrine Metabolic & Immune Disorders-Drug Targets中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Endocrine Metabolic & Immune Disorders-Drug Targets上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Science Immunology030.20
    Cancer Immunology Research6218.80
    Journal of Allergy and Clinical Immunology-In Practice4010.30
    npj Vaccines811.40
    HLA933.00
    Immunity & Ageing3810.90
    OncoImmunology5812.50
    OncoImmunology4912.50
    ALLERGOLOGY INTERNATIONAL4511.80
    Immune Network118.80
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE609549
    BIOMATERIALS519493
    BIOMEDICINE & PHARMACOTHERAPY472925
    Journal of Materials Chemistry B464531
    Frontiers in Pharmacology457213
    Frontiers in Immunology429093
    JOURNAL OF ETHNOPHARMACOLOGY411813
    COLLOIDS AND SURFACES B-BIOINTERFACES407824
    Frontiers in Oncology389590
    Acta Biomaterialia380827
  •  

    Endocrine Metabolic & Immune Disorders-Drug Targets Endocrine Metabolic & Immune Disorders-Drug Targets
    我来预测明年：
    稳步上升 表现平稳 逐渐下降　 刷新
  •  

    		  
  •  

    		  
  •  

    		  
  • 中国学者近期发表的论文
    1.Transcriptional Profiling of TGF-beta Superfamily Members in Lumbar DRGs of Rats Following Sciatic Nerve Axotomy and Activin C Inhibits Neuropathic Pain

    Author: Zhang, Feng-Ming; Wang, Bing; Hu, Han; Li, Qing-Yi; Chen, Hao-Hao; Luo, Li-Ting; Jiang, Zuo-Jie; Zeng, Mei-Xing; Liu, Xing-Jun
    Journal: ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS. 2023; Vol. 23, Issue 3, pp. 375-388. DOI: 10.2174/1871530322666221006114557        PubMed      DOI
    2.A Novel Compound Heterozygous Gene Mutation of Dolichol Kinase Deficiency (DOLK-CDG)

    Author: Yu, Shufeng; Zhang, Ying; Chen, Zhihong; Song, Jiye; Wang, Caixia
    Journal: ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS. 2023; Vol. 23, Issue 2, pp. 235-241. DOI: 10.2174/1871530322666220607123739        PubMed      DOI
    3.Engineered BMSCs-Derived Exosomal miR-542-3p Promotes Cutaneous Wound Healing

    Author: Xiong, Qing-Hua; Zhao, Lei; Wan, Guan-Qun; Hu, Yun-Gang; Li, Xiao-Lin
    Journal: ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS. 2023; Vol. 23, Issue 3, pp. 336-346. DOI: 10.2174/1871530322666220523151713        PubMed      DOI
    4.CD163 in Macrophages: A Potential Biomarker for Predicting the Progression of Diabetic Nephropathy based on Bioinformatics Analysis

    Author: Wang, Xiaoxia; Li, Rui; Liu, Ting; Jia, Yanyan; Gao, Xingxing; Zhang, Xiaodong
    Journal: ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS. 2023; Vol. 23, Issue 3, pp. 294-303. DOI: 10.2174/1871530322666220616102754        PubMed      DOI
    5.The Cytochrome P450 2C19 Polymorphism Associated with Major Adverse Cardiovascular Events Risk in Kazak Patients Undergoing Percutaneous Coronary Intervention and Receiving Clopidogrel

    Author: Wang, Tingting; Feng, Jie; Zhou, Liying; Zhao, Ting; Zhang, Huilan; Shen, Hao; Xu, Li; Sun, Li; Wu, Jianhua; Li, Hongjian; Yu, Luhai
    Journal: ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS. 2023; Vol. 23, Issue 2, pp. 196-204. DOI: 10.2174/1871530322666220523142229        PubMed      DOI
    6.Betulinic Acid Exerts Anti-inflammatory Activity in Human Periodontal Ligament Cells Stimulated with Lipopolysaccharide and/or High Glucose

    Author: Hu, Ping; Zhu, Chunxia
    Journal: ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS. 2023; Vol. 23, Issue 1, pp. 95-104. DOI: 10.2174/1871530322666220509231119        PubMed      DOI
    7.A Review of Structural Features, Biological Functions and Biotransformation Studies in Adipose Tissues and an Assessment of Progress and Implications

    Author: Chu, Ting; Yang, Mao Sheng
    Journal: ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS. 2023; Vol. 23, Issue 1, pp. 12-20. DOI: 10.2174/1871530322666220827145241        PubMed      DOI
    8.Testicular injury attenuated by rapamycin through induction of autophagy and inhibition of endoplasmic reticulum stress in streptozotocin-induced diabetic rats.

    Author: Shi W1, Guo Z2, Yuan R1.
    Journal: Endocr Metab Immune Disord Drug Targets. 2019 Jan 1. doi: 10.2174/1871530319666190102112844. [Epub ahead of print]        PubMed      DOI
    9.B Lymphocytes Are Predictors of Insulin Resistance in Women with Gestational Diabetes Mellitus.

    Author: Zhuang Y1, Zhang J1, Li Y1, Gu H1, Zhao J1, Sun Y1, Wang R1, Zhang C1,2, Chen W1,3, Weng J1, Qi L1, Lu H1, Zhang J1, Liu Q4, He Y1, Xu X1.
    Journal: Endocr Metab Immune Disord Drug Targets. 2019;19(3):358-366. doi: 10.2174/1871530319666190101130300.        PubMed      DOI
    10.New advances of ICG angiography in parathyroid identification.

    Author: Jin H1, Cui M1.
    Journal: Endocr Metab Immune Disord Drug Targets. 2019 Feb 6. doi: 10.2174/1871530319666190206212456. [Epub ahead of print]        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    HARVARD BUSINESS REVIEW02.40
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE1086.10
    Energy Material Advances08.50
    CLINICAL AND EXPERIMENTAL HYPERTENSION453.60
    Journal of Public Transportation07.00
    Asian Journal of Psychiatry010.90
    Chinese Journal of Population Resources and Environment02.60
    VIEW08.60
    HLA933.00
    INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY011.50


以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分：

    同领域作者分享投稿经验：共1条 （包含回复）

 我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

    增值电信业务经营许可证：沪B2-20211595

    礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451